NXTC: NextCure Inc

NXTC新闻

• 12:11 NextCure提供ADC项目更新，报告现金状况
• 12:10 NextCure provides updates on ADC programs, reports cash position
• 13:05 NextCure secures $21.5 million in private placement to extend cash runway
• 13:05 NextCure raises $21.5 million in private placement to fund ADC programs
• 14:55 Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect?
• 12:23 智通港股解盘 | 美国小银行爆雷引发蝴蝶效应 创新药BD引发炒作
• 21:12 Curanex Pharmaceuticals closes $15 million IPO on NASDAQ
• 03:32 NextCure (NXTC) Q2 Loss Widens 71%
• 13:02 NextCure stock soars after positive data for bone disease treatment
• 09:36 Why Deckers Outdoor Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Absci (NASDAQ:ABSI), AST SpaceMobile (NASDAQ:ASTS)
• 13:49 Piper Sandler lowers NextCure stock price target to $15 after reverse split
• 11:22 NextCure initiates one-for-twelve reverse stock split on Nasdaq
• 12:30 Upcoming Stock Splits This Week (July 14 to July 18) – Stay Invested - TipRanks.com
• 13:13 NextCure announces 1-for-12 reverse stock split effective July 14
• 20:20 NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025